The interactions between the Wnt/APC/β-catenin and AKT/mTORC1 pathways may be of particular interest in BHD patients, as this could both elucidate pathophysiology and determine appropriate therapeutic targets. This evidence concerns the gene AKT1 and Birt-Hogg-Dube syndrome.